The abstract is read at the publisher; the summary is JClub's.
Pretherapeutic tumor growth velocity (TGV) measured from serial preoperative MRI independently predicts shorter overall survival in 569 adults with grade 2–3 IDH-mutant lower-grade gliomas, with HR 1.046 per 1-mm/year.
- Why it matters: Current risk stratification for IDH-mutant lower-grade gliomas relies on molecular and surgical burden but misses dynamic tumor behavior that could refine survival prediction.
- What they did: In a multicenter retrospective study from three French centers, automated, outcome-blinded volumetric analysis of serial MRI estimated TGV via mean diameter expansion and log-volume growth, then tested it in multivariable Cox models and external validation.
- The result: Higher TGV remained independently associated with worse OS after adjustment for age, sex, grade, 1p/19q status, and postoperative residual tumor volume, replicated externally (HR 1.077), and improved model fit (likelihood-ratio χ²=5.70; P=.017), especially in astrocytomas.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.